Market Research Logo

European Market Report for Syringes and Needles 2017 - MedCore

European Market Report for Syringes and Needles 2017 - MedCore

The total market comprises two segments: syringes and needles. The syringe segment includes three sub-segments: conventional syringes, safety syringes and insulin syringes. The conventional syringe sub-segment includes two-part and three-part conventional syringes. The insulin syringe sub-segment includes insulin syringes sold with a needle and insulin syringes sold without a needle. The needle sub-segment includes three sub-segments: conventional needles, safety needles and blunt type needles. The majority of syringes and needles in Europe are sold separately and combined when used, but there are some unique markets such as Italy where high sales of syringes and needles already attached make the stand-alone market small by comparison.

Syringes and needles were the first devices used for vascular access, and they are still widely used in Europe. Syringes are used for a variety of applications, including percutaneous injections, injection into catheters, preparation and transport of drugs, blood draws and non-medical applications. Needles connect to syringes and are used for gaining vascular access. They can be sold in combination with syringes or separately. With the aid of needleless connectors such as Luer locks, syringes can be used without needles.


EXECUTIVE SUMMARY
EUROPEAN MARKET FOR VASCULAR ACCESS DEVICES AND ACCESSORIES OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1 RESEARCH SCOPE
1.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.1.1 Human Vascular System
2.2 VASCULAR PATHOLOGY AND DISORDERS
2.2.1 Cancer
2.2.2 End-Stage Renal Disease
2.2.3 Diabetes
PRODUCT ASSESSMENT
3.1 PRODUCT PORTFOLIOS
3.1.1 Syringe and Needles
3.1.1.1 Introduction
3.1.1.2 Allison Medical
3.1.1.2.1 SureComfort™
3.1.1.3 B. Braun
3.1.1.3.1 Injekt®
3.1.1.3.2 Other Syringe & Needle Offerings
3.1.1.4 Becton Dickinson
3.1.1.4.1 BD™ Insulin Syringes
3.1.1.4.2 BD™ Allergy Syringes
3.1.1.4.3 BD™ Tuberculin Syringes
3.1.1.4.4 BD™ Syringes & Needles
3.1.1.4.5 BD PrecisionGlide™ Needles
3.1.1.4.6 BD Safety-Lok™ Syringes
3.1.1.4.7 BD SafetyGlide™ Syringes & Needles
3.1.1.4.8 BD Eclipse™ Needles and Syringes
3.1.1.4.9 BD Integra™ Needles and Syringes
3.1.1.4.10 BD AutoShield™
3.1.1.4.11 Ultra-Fine™
3.1.1.5 Cardinal Health
3.1.1.5.1 Cardinal Health™
3.1.1.6 Delta Hi-Tech, Inc.
3.1.1.6.1 AIMSCO®
3.1.1.7 Medical Plastic Devices, Inc.
3.1.1.7.1 Insupen®
3.1.1.8 Medtronic
3.1.1.8.1 Magellan™
3.1.1.8.2 Monoject™
3.1.1.9 MYCO Medical
3.1.1.9.1 Dispovan®
3.1.1.10 Nipro Medical
3.1.1.10.1 Nipro™
3.1.1.11 Novo Nordisk
3.1.1.11.1 NovoFine®
3.1.1.11.2 NovoTwist®
3.1.1.12 Owen Mumford, Inc.
3.1.1.12.1 Unifine®
3.1.1.13 Perrigo
3.1.1.13.1 Clickfine®
3.1.1.14 Protectus Medical Devices
3.1.1.14.1 Protectus®
3.1.1.15 ReliOn
3.1.1.15.1 ReliOn®
3.1.1.16 Retractable Technologies, Inc.
3.1.1.16.1 VanishPoint®
3.1.1.16.2 Patient Safe®
3.1.1.17 Revolutions Medical
3.1.1.17.1 ReVac™
3.1.1.18 Safety 1st Medical
3.1.1.18.1 Safe-1®
3.1.1.19 Smiths Medical
3.1.1.19.1 Needle-Pro®
3.1.1.20 SOL-MILLENNIUM
3.1.1.20.1 SOL-CARE®
3.1.1.20.2 SOL-M™
3.1.1.20.3 SOL-GUARD™
3.1.1.21 STAT Medical Devices
3.1.1.21.1 Super-Fine™
3.1.1.22 Terumo
3.1.1.22.1 SurGuard®
3.1.1.22.2 TERUMO®
3.1.1.23 UltiCare
3.1.1.23.1 UltiCare®
3.2 REGULATORY ISSUES AND RECALLS
3.2.1 November 2015
3.2.2 October 2015
3.2.3 September 2015
3.2.4 August 2015
3.2.5 July 2015
3.2.6 April 2015
3.2.7 March 2015
3.2.8 February 2015
3.2.9 January 2015
3.2.10 December 2014
3.2.11 October 2014
3.2.12 September 2014
3.2.13 May 2014
3.2.14 April 2014
3.2.15 March 2014
3.2.16 January 2014
3.2.17 December 2013
3.2.18 September 2013
3.2.19 August 2013
3.2.20 June 2013
3.2.21 March 2013
3.2.22 February 2013
3.2.23 December 2012
3.2.24 August 2012
3.2.25 June 2012
3.2.26 May 2012
3.2.27 March 2012
3.2.28 February 2012
3.2.29 January 2012
3.3 CLINICAL TRIALS
3.3.1 Syringe and Needles
3.4 PRODUCT PIPELINES
3.4.1 Alliance Vascular Devices, LLC
3.4.1.1 FreeHand Safety Huber Needle®
3.4.2 AngioDynamics
3.4.2.1 Celerity™ PICC Tip Confirmation System with Navigation
3.4.2.2 Firefly
3.4.2.3 BioFlo® PICC Line Extension
3.4.2.4 BioFlo® Port Line Extension
3.4.2.5 Next Generation BioFlo® PICC
3.4.2.6 Next Generation BioFlo® Port
3.4.3 Bluegrass Vascular Technologies, Inc.
3.4.3.1 Surfacer® Inside-Out™ Access System
3.4.4 C.R. Bard
3.4.4.1 Chemical-Resistant PICCs
3.4.4.2 Novel Advanced Material PICCs
3.4.4.3 PowerGlide® Pro Midline
3.4.4.4 AccuCath®
3.4.4.5 Xenesis™ Acute Hemodialysis Catheter
3.4.4.6 Site~Rite® 8 Ultrasound System
3.4.5 M. C. Johnson
3.4.5.1 PICC Securement Device
3.4.6 Nipro Medical
3.4.6.1 Shielding Safety Needle
3.4.6.2 Safety Syringe
3.4.6.3 Safety PIVC
3.4.7 Parasol Medical
3.4.7.1 Catheter Securement Device
3.4.8 PAVmed Inc.
3.4.8.1 NextCath™
3.4.9 Phase One Medical
3.4.9.1 Goldilocks™ Long Term Hemodialysis Catheter
3.4.9.2 Triple-Lumen Symetrex™ Hemodialysis Catheter
3.4.10 Prodigy Diabetes Care, LLC.
3.4.10.1 Insulin Pen Needles
3.4.11 Sharklet Technologies, Inc.
3.4.11.1 Sharklet™ Central Venous Catheter
3.4.12 Starboard Medical
3.4.12.1 Catheter Securement Devices
3.4.13 Teleflex Medical
3.4.13.1 Arrow® Endurance™ Extended Dwell Peripheral Catheter System
3.4.13.2 Tip Confirmation for CVCs, Chronic Hemodialysis Catheters & Ports
3.4.14 Vascular Access Technologies, Inc.
3.4.14.1 SAFECVAD™
COUNTRY PROFILES
4.1 INTRODUCTION
4.1.1 Population
4.1.2 GDP Per Capita
4.1.3 Price Index
4.2 GERMANY
4.3 FRANCE
4.4 UNITED KINGDOM
4.5 ITALY
4.6 SPAIN
4.7 BENELUX
4.8 SCANDINAVIA
4.9 AUSTRIA
4.10 SWITZERLAND
4.11 PORTUGAL
SYRINGE AND NEEDLE MARKET
5.1 INTRODUCTION
5.1.1 Two-Part and Three-Part Syringes
5.1.2 Safety Devices
5.1.3 Insulin Syringes
5.2 MARKET OVERVIEW
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total Syringe and Needle Market
5.3.2 Total Syringe Market
5.3.2.1 Total Conventional Syringe Market
5.3.2.1.1 Two-Part Conventional Syringe Market
5.3.2.1.2 Three-Part Conventional Syringe Market
5.3.2.2 Safety Syringe Market
5.3.2.3 Total Insulin Syringe Market
5.3.2.3.1 Insulin Syringe with Needle Market
5.3.2.3.2 Insulin Syringe without Needle Market
5.3.3 Total Needle Market
5.3.3.1 Conventional Needle Market
5.3.3.2 Safety Needle Market
5.3.3.3 Blunt Type Needle Market
5.4 DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE MARKET SHARE ANALYSIS
ABBREVIATIONS
APPENDIX: COMPANY PRESS RELEASES
List of Charts
Chart 1 1: Vascular Access Device and Accessories Market by Segment, Europe, 2013 – 2023
Chart 1 2: Vascular Access Device and Accessories Market Overview, Europe, 2016 & 2023
Chart 4 1: Country Profile, Germany, 2016
Chart 4 2: Country Profile, France, 2016
Chart 4 3: Country Profile, United Kingdom, 2016
Chart 4 4: Country Profile, Italy, 2016
Chart 4 5: Country Profile, Spain, 2016
Chart 4 6: Country Profile, Benelux, 2016
Chart 4 7: Country Profile, Scandinavia, 2016
Chart 4 8: Country Profile, Austria, 2016
Chart 4 9: Country Profile, Switzerland, 2016
Chart 4 10: Country Profile, Portugal, 2016
Chart 5 1: Syringe and Needle Market by Segment, Europe, 2013 – 2023
Chart 5 2: Syringe and Needle Market by Segment, Europe, 2016
Chart 5 3: Syringe and Needle Market by Segment, Europe, 2023
Chart 5 4: Total Syringe and Needle Market, Europe, 2013 – 2023
Chart 5 5: Total Conventional Syringe Market, Europe, 2013 – 2023
Chart 5 6: Safety Syringe Market, Europe, 2013 – 2023
Chart 5 7: Total Insulin Syringe Market, Europe, 2013 – 2023
Chart 5 8: Conventional Needle Market, Europe, 2013 – 2023
Chart 5 9: Safety Needle Market, Europe, 2013 – 2023
Chart 5 10: Blunt Type Needle Market, Europe, 2013 – 2023
Chart 5 11: Leading Competitors, Syringe and Needle Market, Europe, 2016
List of Figures
Figure 1 1: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016 (1 of 2)
Figure 1 2: Vascular Access Device and Accessories Competitor Market Share Ranking by Segment, Europe, 2016 (2 of 2)
Figure 1 3: Companies Researched in this Report, Europe, 2016
Figure 1 4: Factors Impacting the Vascular Access Device and Accessories Market by Segment, Europe, 2016
Figure 1 5: Recent Events in the Vascular Access Device and Accessories Market, Europe, 2013 – 2016
Figure 1 6: Vascular Access Procedures Covered, Europe, 2016
Figure 1 7: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (1 of 3)
Figure 1 8: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (2 of 3)
Figure 1 9: Vascular Access Device and Accessories Markets Covered, Europe, 2016 (3 of 3)
Figure 1 10: Key Report Updates
Figure 1 11: Version History
Figure 3 1: Class 2 Device Recall Medtronic
Figure 3 2: Class 2 Device Recall Smiths Medical
Figure 3 3: Class 2 Device Recall Arrow
Figure 3 4: Class 2 Device Recall Arrow
Figure 3 5: Class 2 Device Recall Covidien (Medtronic)
Figure 3 6: Class 2 Device Recall Arrow
Figure 3 7: Class 2 Device Recall Medline
Figure 3 8: Class 2 Device Recall Arrow
Figure 3 9: Class 2 Device Recall B. Braun
Figure 3 10: Class 3 Device Recall Bard Access
Figure 3 11: Class 2 Device Recall Covidien (Medtronic)
Figure 3 12: Class 2 Device Recall Bard Access
Figure 3 13: Class 2 Device Recall Bard Access
Figure 3 14: Class 2 Device Recall Medcomp & AngioDynamics
Figure 3 15: Class 2 Device Recall Bard Access
Figure 3 16: Class 2 Device Recall Arrow
Figure 3 17: Class 2 Device Recall Medcomp
Figure 3 18: Class 2 Device Recall Arrow
Figure 3 19: Class 2 Device Recall Arrow
Figure 3 20: Class 2 Device Recall Smiths Medical
Figure 3 21: Class 2 Device Recall PFM Medical
Figure 3 22: Class 2 Device Recall PFM Medical
Figure 3 23: Class 2 Device Recall Becton Dickinson
Figure 3 24: Class 2 Device Recall Arrow
Figure 3 25: Class 2 Device Recall Arrow
Figure 3 26: Class 2 Device Recall Navilyst Medical
Figure 3 27: Class 2 Device Recall Argon Medical
Figure 3 28: Class 2 Device Recall Arrow
Figure 3 29: Class 2 Device Recall Arrow
Figure 3 30: Class 2 Device Recall Arrow
Figure 3 31: Class 2 Device Recall Bard Access
Figure 3 32: Class 2 Device Recall Navilyst Medical
Figure 3 33: Class 2 Device Recall Bard Access
Figure 3 34: Class 2 Device Recall Smiths Medical
Figure 3 35: Class 2 Device Recall B. Braun
Figure 3 36: Class 2 Device Recall Smiths Medical
Figure 3 37: Class 2 Device Recall Access Scientific
Figure 3 38: Class 2 Device Recall Covidien (Medtronic)
Figure 3 39: Class 2 Device Recall Arrow
Figure 3 40: Class 2 Device Recall Bard Access
Figure 3 41: Class 2 Device Recall Becton Dickinson
Figure 3 42: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 43: Class 2 Device Recall Bard Access
Figure 3 44: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 45: Class 2 Device Recall Medcomp
Figure 3 46: Class 2 Device Recall Becton Dickinson
Figure 3 47: Class 3 Device Recall Bard Access
Figure 3 48: Class 2 Device Recall Medcomp
Figure 3 49: Class 1 Device Recall Arrow
Figure 3 50: Class 2 Device Recall Arrow
Figure 3 51: Class 2 Device Recall Vygon
Figure 3 52: Class 2 Device Recall Covidien (Medtronic)
Figure 3 53: Class 2 Device Recall Medcomp
Figure 3 54: Class 2 Device Recall Churchill Medical Systems, Inc. A Vygon Company
Figure 3 55: Class 2 Device Recall Christie Medical Holdings
Figure 3 56: Class 3 Recall Bard Access
Figure 3 57: Class 2 Device Recall AngioDynamics
Figure 3 58: Class 2 Device Recall Becton Dickinson
Figure 3 59: Class 2 Device Recall AngioDynamics
Figure 3 60: Class 2 Device Recall AngioDynamics
Figure 3 61: Class 3 Device Recall AngioDynamics
Figure 3 62: Class 2 Device Recall AngioDynamics
Figure 3 63: A Randomized, Parallel Design Study
Figure 3 64: Pen Torch Transillumination: Shedding Light on Difficult Venepuncture
Figure 3 65: Transition From Parenteral Prostanoids to Inhaled Treprostinil
Figure 3 66: Efficacy, Safety and Acceptability of the New Pen Needle
Figure 3 67: A Phase I Study of the Safety, Reactogenicity, Acceptability and Immunogenicity
Figure 3 68: A Single Centre, Randomised, 3-period Cross-over Trial
Figure 3 69: A Phase IV, Non-Inferiority, Observer Blind, Randomized Clinical Study
Figure 3 70: Treating Diabetic Lipohypertrophy With Intensive Education
Figure 3 71: Pharmacokinetic Comparison of Intradermal Versus Sub-cutaneous Insulin
Figure 3 72: A Randomized, Multi-centre Cross-over Study
Figure 3 73: A Clinical Investigation to Evaluate the Safety and Performance
Figure 3 74: A Phase I, Randomized, Open-Label, Parallel-Group, Single-Dose, Multi-Center Study
Figure 3 75: Pharmacokinetic and Pharmacodynamic Profile of Insulin Lispro
Figure 3 76: Reproducibility of Insulin Action When Administered by Needle-free Jet Injection
Figure 3 77: Patient Experiences With Injection Needles
Figure 3 78: Inactivated Influenza Via Jet Injection
Figure 3 79: Intradermal Rabies Immunization Using NanoJect: A Comparative Study
Figure 3 80: Phase 1b, Partial-Blind, Parallel Group, Randomized Study
Figure 3 81: A Phase I, Open Label, CT to Evaluate the Safety, Tolerability and Immunogenicity
Figure 5 1: Syringe and Needle Market by Segment, Europe, 2013 – 2023 (€M)
Figure 5 2: Syringe and Needle Market by Segment, Europe, 2013 – 2023 (US$M)
Figure 5 3: Total Syringe and Needle Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 4: Units Sold by Country, Total Syringe and Needle Market, Europe, 2013 – 2023
Figure 5 5: Average Selling Price by Country, Total Syringe and Needle Market, Europe, 2013 – 2023 (€)
Figure 5 6: Average Selling Price by Country, Total Syringe and Needle Market, Europe, 2013 – 2023 (US$)
Figure 5 7: Market Value by Country, Total Syringe and Needle Market, Europe, 2013 – 2023 (€M)
Figure 5 8: Market Value by Country, Total Syringe and Needle Market, Europe, 2013 – 2023 (US$M)
Figure 5 9: Total Syringe Market, Europe, 2013 – 2023, (€ and US$)
Figure 5 10: Units Sold by Country, Total Syringe Market, Europe, 2013 – 2023
Figure 5 11: Average Selling Price by Country, Total Syringe Market, Europe, 2013 – 2023 (€)
Figure 5 12: Average Selling Price by Country, Total Syringe Market, Europe, 2013 – 2023 (US$)
Figure 5 13: Market Value by Country, Total Syringe Market, Europe, 2013 – 2023 (€M)
Figure 5 14: Market Value by Country, Total Syringe Market, Europe, 2013 – 2023 (US$M)
Figure 5 15: Total Conventional Syringe Market, Europe, 2013 – 2023, (€ and US$)
Figure 5 16: Units Sold by Country, Total Conventional Syringe Market, Europe, 2013 – 2023
Figure 5 17: Average Selling Price by Country, Total Conventional Syringe Market, Europe, 2013 – 2023 (€)
Figure 5 18: Average Selling Price by Country, Total Conventional Syringe Market, Europe, 2013 – 2023 (US$)
Figure 5 19: Market Value by Country, Total Conventional Syringe Market, Europe, 2013 – 2023 (€M)
Figure 5 20: Market Value by Country, Total Conventional Syringe Market, Europe, 2013 – 2023 (US$M)
Figure 5 21: Two-Part Conventional Syringe Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 22: Units Sold by Country, Two-Part Conventional Syringe Market, Europe, 2013 – 2023
Figure 5 23: Average Selling Price by Country, Two-Part Conventional Syringe Market, Europe, 2013 – 2023 (€)
Figure 5 24: Average Selling Price by Country, Two-Part Conventional Syringe Market, Europe, 2013 – 2023 (US$)
Figure 5 25: Market Value by Country, Two-Part Conventional Syringe Market, Europe, 2013 – 2023 (€M)
Figure 5 26: Market Value by Country, Two-Part Conventional Syringe Market, Europe, 2013 – 2023 (US$M)
Figure 5 27: Three-Part Conventional Syringe Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 28: Units Sold by Country, Three-Part Conventional Syringe Market, Europe, 2013 – 2023
Figure 5 29: Average Selling Price by Country, Three-Part Conventional Syringe Market, Europe, 2013 – 2023 (€)
Figure 5 30: Average Selling Price by Country, Three-Part Conventional Syringe Market, Europe, 2013 – 2023 (US$)
Figure 5 31: Market Value by Country, Three-Part Conventional Syringe Market, Europe, 2013 – 2023 (€M)
Figure 5 32: Market Value by Country, Three-Part Conventional Syringe Market, Europe, 2013 – 2023 (US$M)
Figure 5 33: Safety Syringe Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 34: Units Sold by Country, Safety Syringe Market, Europe, 2013 – 2023
Figure 5 35: Average Selling Price by Country, Safety Syringe Market, Europe, 2013 – 2023 (€)
Figure 5 36: Average Selling Price by Country, Safety Syringe Market, Europe, 2013 – 2023 (US$)
Figure 5 37: Market Value by Country, Safety Syringe Market, Europe, 2013 – 2023 (€M)
Figure 5 38: Market Value by Country, Safety Syringe Market, Europe, 2013 – 2023 (US$M)
Figure 5 39: Total Insulin Syringe Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 40: Units Sold by Country, Total Insulin Syringe Market, Europe, 2013 – 2023
Figure 5 41: Average Selling Price by Country, Total Insulin Syringe Market, Europe, 2013 – 2023 (€)
Figure 5 42: Average Selling Price by Country, Total Insulin Syringe Market, Europe, 2013 – 2023 (US$)
Figure 5 43: Market Value by Country, Total Insulin Syringe Market, Europe, 2013 – 2023 (€M)
Figure 5 44: Market Value by Country, Total Insulin Syringe Market, Europe, 2013 – 2023 (US$M)
Figure 5 45: Insulin Syringe with Needle Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 46: Insulin Syringe without Needle Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 47: Total Needle Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 48: Units Sold by Country, Total Needle Market, Europe, 2013 – 2023
Figure 5 49: Average Selling Price by Country, Total Needle Market, Europe, 2013 – 2023 (€)
Figure 5 50: Average Selling Price by Country, Total Needle Market, Europe, 2013 – 2023 (US$)
Figure 5 51: Market Value by Country, Total Needle Market, Europe, 2013 – 2023 (€M)
Figure 5 52: Market Value by Country, Total Needle Market, Europe, 2013 – 2023 (US$M)
Figure 5 53: Conventional Needle Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 54: Units Sold by Country, Conventional Needle Market, Europe, 2013 – 2023
Figure 5 55: Average Selling Price by Country, Conventional Needle Market, Europe, 2013 – 2023 (€)
Figure 5 56: Average Selling Price by Country, Conventional Needle Market, Europe, 2013 – 2023 (US$)
Figure 5 57: Market Value by Country, Conventional Needle Market, Europe, 2013 – 2023 (€M)
Figure 5 58: Market Value by Country, Conventional Needle Market, Europe, 2013 – 2023 (US$M)
Figure 5 59: Safety Needle Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 60: Units Sold by Country, Safety Needle Market, Europe, 2013 – 2023
Figure 5 61: Average Selling Price by Country, Safety Needle Market, Europe, 2013 – 2023 (€)
Figure 5 62: Average Selling Price by Country, Safety Needle Market, Europe, 2013 – 2023 (US$)
Figure 5 63: Market Value by Country, Safety Needle Market, Europe, 2013 – 2023 (€M)
Figure 5 64: Market Value by Country, Safety Needle Market, Europe, 2013 – 2023 (US$M)
Figure 5 65: Blunt Type Needle Market, Europe, 2013 – 2023 (€ and US$)
Figure 5 66: Drivers and Limiters, Syringe and Needle Market, Europe, 2016
Figure 5 67: Leading Competitors by Country, Syringe and Needle Market, Europe, 2016
Figure 7 1: Press Release Summary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report